Kimia Biosciences Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 261.45 million compared to INR 288.02 million a year ago. Revenue was INR 267.21 million compared to INR 290.66 million a year ago. Net loss was INR 19.52 million compared to INR 34.61 million a year ago. Basic loss per share from continuing operations was INR 0.41 compared to INR 0.73 a year ago. Diluted loss per share from continuing operations was INR 0.41 compared to INR 0.73 a year ago.
For the nine months, sales was INR 745.75 million compared to INR 1,058.53 million a year ago. Revenue was INR 759.14 million compared to INR 1,067.03 million a year ago. Net loss was INR 71.04 million compared to INR 31.87 million a year ago. Basic loss per share from continuing operations was INR 1.5 compared to INR 0.67 a year ago. Diluted loss per share from continuing operations was INR 1.5 compared to INR 0.67 a year ago.